Posts Tagged: Alexion
Connecticut-based Alexion Pharmaceuticals, Inc. agreed to pay $21.4 million to resolve SEC charges that the company violated the FCPA by bribing foreign officials in Turkey and Russia, and failing to maintain accurate books and records at subsidiaries in Brazil and Colombia.… Continue Reading
During the second calendar quarter — amid the Covid-19 lockdown — there were two corporate FCPA enforcement actions. For comparison, during the second calendar quarter last year, there were three corporate FCPA enforcement actions, and during Q2 2018, there were five corporate FCPA enforcement actions.… Continue Reading
Alexion Pharmaceuticals Inc. said in a securities filing that the Justice Department is now investigating the company’s grant-making activities and its compliance with the Foreign Corrupt Practices Act.
Connecticut-based Alexion received a subpoena from the SEC in May.… Continue Reading